Protective Effects of Growth Differentiation Factor-6 on the Intervertebral Disc: An In Vitro and In Vivo Study
Authors:
- Kunihiko MiyazakiKMKunihiko Miyazaki
- Shingo MiyazakiSMShingo Miyazaki
- Takashi YurubeTakashi Yurube
- Yoshiki TakeokaYTYoshiki Takeoka
- Yutaro KandaYKYutaro Kanda
- Zhongying ZhangZZZhongying Zhang
- Yuji KakiuchiYKYuji Kakiuchi
- Ryu TsujimotoRTRyu Tsujimoto
- Hiroki OhnishiHOHiroki Ohnishi
- Tomoya MatsuoTMTomoya Matsuo
- Masao RyuMRMasao Ryu
- Ryosuke KurodaRKRyosuke Kuroda
Open Access
Abstract
Growth differentiation factors (GDFs) regulate homeostasis by amplifying extracellular matrix anabolism and inhibiting pro-inflammatory cytokine production in the intervertebral disc (IVD). The aim of this study was to elucidate the effects of GDF-6 on human IVD nucleus pulposus (NP) cells using a three-dimensional culturing system in vitro and on rat tail IVD tissues using a puncture model in vivo. In vitro, Western blotting showed decreased GDF-6 expression with age and degeneration severity in surgically collected human IVD tissues (n = 12). Then, in moderately degenerated human IVD NP cells treated with GDF-6 (100 ng/mL), immunofluorescence demonstrated an increased expression of matrix components including aggrecan and type II collagen. Quantitative polymerase chain reaction analysis also presented GDF-6-induced downregulation of pro-inflammatory tumor necrosis factor (TNF)-α (p = 0.014) and interleukin (IL)-6 (p = 0.016) gene expression stimulated by IL-1β (10 ng/mL). Furthermore, in the mitogen-activated protein kinase pathway, Western blotting displayed GDF-6-induced suppression of p38 phosphorylation (p = 0.041) under IL-1β stimulation. In vivo, intradiscal co-administration of GDF-6 and atelocollagen was effective in alleviating rat tail IVD annular puncture-induced radiologic height loss (p = 0.005), histomorphological degeneration (p < 0.001), matrix metabolism (aggrecan, p < 0.001; type II collagen, p = 0.001), and pro-inflammatory cytokine production (TNF-α, p < 0.001; IL-6, p < 0.001). Consequently, GDF-6 could be a therapeutic growth factor for degenerative IVD disease.Keywords
Funding Information
- JSPS KAKENHI (JP19K18464)
This publication has 46 references indexed in Scilit:
- Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine StudyAnnals of the Rheumatic Diseases, 2011
- Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cellsArthritis Research & Therapy, 2009
- A Simple Disc Degeneration Model Induced by Percutaneous Needle Puncture in the Rat TailSpine, 2008
- The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cellsThe Spine Journal, 2008
- Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndromeHuman Mutation, 2008
- A systematic review of low back pain cost of illness studies in the United States and internationallyThe Spine Journal, 2008
- Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral discThe Journal of Pathology, 2004
- Atelocollagen for protein and gene deliveryAdvanced Drug Delivery Reviews, 2003
- Phenotypic Characteristics of Rabbit Intervertebral Disc CellsSpine, 1999
- The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.Journal of Clinical Investigation, 1996